Ionically Crosslinked Chitosan Nanoparticles as Gene Delivery Systems: Effect of PEGylation Degree on In Vitro and In Vivo Gene Transfer

被引:58
作者
Csaba, Noemi [1 ]
Koping-Hoggard, Magnus [1 ]
Fernandez-Megia, Eduardo [2 ]
Novoa-Carballal, Ramon [2 ]
Riguera, Ricardo [2 ]
Jose Alonso, Maria [1 ]
机构
[1] Univ Santiago de Compostela, Dept Pharm & Pharmaceut Technol, Sch Pharm, Santiago De Compostela 15782, Spain
[2] Univ Santiago de Compostela, Dept Organ Chem, Fac Chem, Santiago De Compostela 15782, Spain
关键词
Nanoparticles; Chitosan; Polyethylene Glycol; Gene Delivery; Vaccine; NASAL VACCINE DELIVERY; DNA NANOPARTICLES; PEG NANOPARTICLES; PROTEIN CARRIERS; DRUG; FORMULATION; PARTICLES; COMPLEXES; DENSITY;
D O I
10.1166/jbn.2009.1017
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The purpose of this work was to develop a new type of nanoparticles made of PEG-grafted chitosans (CS-g-PEG) using tripolyphosphate (TPP) as a polyanionic crosslinker and to investigate the potential of these nanostructures as gene carriers. The formation of these nanoparticles was optimised by the evaluation of the combined effects of pH, PEGylation degree and chitosan/crosslinker ratio on the particle formation. The selected CS-g-PEG/TPP nanoparticles were studied with regard to their physico-chemical properties, DNA association efficiency as well as to their toxicity and gene expression in vitro. Furthermore, the best performing nanoparticle prototypes were also evaluated for their potential for in vivo gene delivery. CS-g-PEG/TPP nanoparticles displayed a high DNA association efficiency combined with high stability and low cellular toxicity. The results of the in vitro transfection assays showed positive effects of the PEGylation in the case of particles prepared from high molecular weight chitosan, while the presence of PEG slightly decreased the efficiency of the nanoparticles based on low molecular weight chitosan. Overall, high and long lasting gene expression levels could be observed for all types of nanoparticles. Moreover, CS-g-PEG/TPP nanoparticles also mediated high gene expression levels in vivo, following nasal administration. These results indicate the potential of ionically crosslinked CS-g-PEG/TPP nanoparticles as transmucosal gene delivery systems.
引用
收藏
页码:162 / 171
页数:10
相关论文
共 40 条
[1]   Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26 [J].
Aktas, Y ;
Yemisci, M ;
Andrieux, K ;
Gürsoy, RN ;
Alonso, MJ ;
Fernandez-Megia, E ;
Novoa-Carballal, R ;
Quiñoá, E ;
Riguera, R ;
Sargon, MF ;
Çelik, HH ;
Demir, AS ;
Hincal, AA ;
Dalkara, T ;
Çapan, Y ;
Couvreur, P .
BIOCONJUGATE CHEMISTRY, 2005, 16 (06) :1503-1511
[2]  
Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
[3]  
2-4
[4]   Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines [J].
Calvo, P ;
RemunanLopez, C ;
VilaJato, JL ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 1997, 14 (10) :1431-1436
[5]   Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles [J].
Corsi, K ;
Chellat, F ;
Yahia, L ;
Fernandes, JC .
BIOMATERIALS, 2003, 24 (07) :1255-1264
[6]  
Csaba N, 2004, EUR J PHARM SCI, V23, pS55
[7]  
Csaba Noemi, 2006, Expert Opin Drug Deliv, V3, P463, DOI 10.1517/17425247.3.4.463
[8]   Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles:: Influence on physical stability and in vitro cell uptake [J].
De Jaeghere, F ;
Allémann, E ;
Leroux, JC ;
Stevels, W ;
Feijen, J ;
Doelker, E ;
Gurny, R .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :859-866
[9]   Optimal routine conditions for the determination of the degree of acetylation of chitosan by 1H-NMR [J].
Fernandez-Megia, E ;
Novoa-Carballal, R ;
Quiñoá, E ;
Riguera, R .
CARBOHYDRATE POLYMERS, 2005, 61 (02) :155-161
[10]  
Fernández-Urrusuno R, 1999, STP PHARMA SCI, V9, P429